AstraZeneca CEO on Covid-19 vaccine efforts, BARDA funding and more

AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority (BARDA) to develop a coronavirus vaccine from the University of Oxford. Pascal Soriot, CEO of AstraZeneca, joins "Squawk Box" and CNBC's Meg Tirrell to discuss the company's efforts to develop a Covid-19 vaccine.
07:13
Thu, May 21 20209:00 AM EST